PFA
CELG

Pathway Financial Advisors’s Celgene Corp CELG Stock Holding History

Pathway Financial Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-723
Closed -$57K – 435
2018
Q2 		$57K Hold
723
– – 0.03% 237
2018
Q1 		$64K Hold
723
– – 0.04% 214
2017
Q4 		$75K Buy
+723
New +$81.6K 0.04% 194

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pathway Financial Advisors's CELG Position: Q3 2018 in Review

Pathway Financial Advisors sold out of Celgene Corp (CELG) in Q3 2018, closing a stake of 723 shares — an estimated $57K sold.

Pathway Financial Advisors first reported a position in CELG in Q4 2017 and held it in 3 quarters. The position peaked at $75K in Q4 2017. 1,364 funds tracked by Wall St. Rank hold CELG as of Q3 2018.

  • Pathway Financial Advisors reported no remaining Celgene Corp position as of Q3 2018 after selling out during the quarter.
  • Pathway Financial Advisors sold 723 Celgene Corp shares in Q3 2018, an estimated $57K.
  • Pathway Financial Advisors first reported a position in Celgene Corp in Q4 2017 and held it in 3 quarters.
  • Pathway Financial Advisors's Celgene Corp position peaked at $75K in Q4 2017.
  • 1,364 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2018.

Based on Pathway Financial Advisors's 13F filing for Q3 2018, filed 16 Jan 2019.